January 31, 2020

Genetics Signatures (ASX:GSS) – Appendix 4C & Quarterly Report

November 5, 2019

Genetics Signatures (ASX:GSS) – Appendix 3B

Genetics Signatures (ASX:GSS) – Notice of Extraordinary General Meeting & Proxy Form

November 7, 2019

Genetics Signatures (ASX:GSS) – Investor Presentation

November 29, 2019

Genetics Signatures (ASX:GSS) – Chairman’s address to AGM

February 17, 2020

Genetics Signatures (ASX:GSS) – Appendix 3G

February 28, 2020

Genetics Signatures (ASX:GSS) – Half Yearly Report and Accounts

April 1, 2015

Genetic Signatures lists on the ASX

April 10, 2015

Completion of first customer site installation of new EasyScreen™ Respiratory Virus Detection Kit

April 27, 2015

Quarterly Cash Flow Report – GSS Appendix 4C 31 March 2015

May 25, 2015

25th May 2015 – GSS Non-Deal Roadshow Presentation

July 20, 2015

CFO Presentation at 2015 Bioshares Biotech Summit

Genetic Signatures CFO Rob Birrell recently presented at the 11th Bioshares Biotech Summit in Queenstown held on Friday 17- Saturday 18 July, 2015. The presentation featured in a session titled New IPOs, with a focus on biotech companies that have listed in the last 12 months, their respective IPO experiences and the value propositions of the newly listed companies. The presentation slides can be downloaded here


About the Bioshares Biotech Summit: The Summit is organised by Bioshares, Australia’s leading independent biotech investment publication. Attendees include biotech executives, fund managers and, retail investors.